FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

Viscosity-dependent behaviors such as drips, stringiness, and air entrapment can destabilize fill accuracy and visual inspection, necessitating tailored methodologies and tighter process controls.

Aseptic PFS production integrates validated mixing, 0.2 μm sterile filtration, Annex 1/USP-aligned controls, and CCI verification to support sterility assurance throughout shelf life.

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

HUNT VALLEY, Md.--(BUSINESS WIRE)--Pharmaceutics International, Inc. (Pii), a leading contract development and manufacturing organization (CDMO), has announced a significant expansion of its prefilled ...

The MarketWatch News Department was not involved in the creation of this content. Prefilled Syringes Market to Surpass USD 18 Bn by 2031 as Biologics and Self-Injection Devices Drive Adoption, Says ...